[1]
K. Pant and A. Singh, “Overview on Chemokine Co-Receptor-5 (CCR-5) HIV-1 Entry Inhibitors”, J. Drug Delivery Ther., vol. 8, no. 4, pp. 73–79, Jul. 2018, doi: 10.22270/jddt.v8i4.1794.